Barclays’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$690K Buy
50,098
+43,793
+695% +$660K ﹤0.01% 2983
2025
Q4
$114K Buy
6,305
+3,582
+132% +$64.3K ﹤0.01% 4545
2025
Q3
$50.5K Sell
2,723
-137,314
-98% -$2.16M ﹤0.01% 4765
2025
Q2
$2.24M Sell
140,037
-13,987
-9% -$249K ﹤0.01% 2757
2025
Q1
$2.99M Sell
154,024
-291,771
-65% -$6.14M ﹤0.01% 2325
2024
Q4
$9.82M Buy
445,795
+182,138
+69% +$3.51M ﹤0.01% 1590
2024
Q3
$4.44M Buy
263,657
+59,395
+29% +$881K ﹤0.01% 2190
2024
Q2
$2.44M Sell
204,262
-99,740
-33% -$1.11M ﹤0.01% 2000
2024
Q1
$3.37M Buy
304,002
+212,779
+233% +$2.17M ﹤0.01% 2131
2023
Q4
$790K Buy
91,223
+75,615
+484% +$588K ﹤0.01% 3614
2023
Q3
$119K Buy
15,608
+1,982
+15% +$14.9K ﹤0.01% 3531
2023
Q2
$98.1K Buy
+13,626
New +$79.4K ﹤0.01% 3573

Other funds holding CLBT